In line with previous studies, this study revealed that invasive BC patients in the low-TSR group had a worse 5-DFS compared with patients in the high-TSR group, and the TSR was not associated with age, menopausal status, T stage, N status, histological grade, ER status, and HER2 gene status. This evidence concerns the gene ESR1 and breast cancer.